A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors
Biochemistry & Molecular Biology
Virulence Factors
INNATE
BINDING PROTEIN
DOMAIN-CONTAINING PROTEINS
Cell Line
03 medical and health sciences
Bacterial Proteins
Pseudomonas
Receptors
Humans
Immune Evasion
TLR adaptors
08 Information And Computing Sciences
0303 health sciences
Science & Technology
CYSTIC-FIBROSIS
Membrane Glycoproteins
Virulence
TIR domain
BRUCELLA-MELITENSIS
Toll-Like Receptors
ESCRT-I COMPLEX
Receptors, Interleukin-1
Epithelial Cells
Cell Biology
11 Medical And Health Sciences
Articles
06 Biological Sciences
virulence
ESCHERICHIA-COLI
UBAP1
Myeloid Differentiation Factor 88
Pseudomonas aeruginosa
SECRETION
Carrier Proteins
Life Sciences & Biomedicine
RECEPTOR SIGNAL-TRANSDUCTION
TOLL
Interleukin-1
Developmental Biology
DOI:
10.15252/embj.201695343
Publication Date:
2017-05-09T00:10:41Z
AUTHORS (15)
ABSTRACT
AbstractBacterial pathogens often subvert the innate immune system to establish a successful infection. The direct inhibition of downstream components of innate immune pathways is particularly well documented but how bacteria interfere with receptor proximal events is far less well understood. Here, we describe a Toll/interleukin 1 receptor (TIR) domain‐containing protein (PumA) of the multi‐drug resistant Pseudomonas aeruginosa PA7 strain. We found that PumA is essential for virulence and inhibits NF‐κB, a property transferable to non‐PumA strain PA14, suggesting no additional factors are needed for PumA function. The TIR domain is able to interact with the Toll‐like receptor (TLR) adaptors TIRAP and MyD88, as well as the ubiquitin‐associated protein 1 (UBAP1), a component of the endosomal‐sorting complex required for transport I (ESCRT‐I). These interactions are not spatially exclusive as we show UBAP1 can associate with MyD88, enhancing its plasma membrane localization. Combined targeting of UBAP1 and TLR adaptors by PumA impedes both cytokine and TLR receptor signalling, highlighting a novel strategy for innate immune evasion.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....